Fibrinolytic Activity of Lung and Spleen Extracts Observed in Conventional but not in Germ-Free Rats

Summary

Protease-like activity which split plasminogen-free fibrin was demonstrated in 2 M KSCN extracts of the lung and spleen of conventional rats. The activity was virtually undetectable in tissue extracts from germ-free rats. The extracts from the conventional rat tissues split fibrin and fibrinogen remarkably at neutral pH, but not casein, when examined using fibrin, fibrinogen-agar and casein-agar plates. The fibrinolytic activity was inhibited by STI and DFP, indicating a serine protease nature. The activity was not inhibited by TLCK, t-AMCHA or dansyl-L-arginine-methylpiperidine amide (a selective synthetic thrombin inhibitor, OM₁₈₉). It was neither activated nor inhibited by cysteine, KCN or iodoacetic acid. The results obtained indicate that the protease-like activity of the lung and spleen extracted with 2 M KSCN from conventional rats has properties which differ from those of trypsin, plasmin, plasminogen-activator, thrombin, and cathepsin A, B and C.

• References

• 1 Ahlgren T, Berghem H, Lagergren H, Lahnborg G, Schildt B. 1976; Phagocytic and catabolic function of the reticuloendothelial system in dogs subjected to defibrinogenation. Thrombosis Research 8: 819
• 2 Astrup T, Albrechtsen DK. 1957; Estimation of the plasminogen activator and trypsin inhibitor in animals and human tissues. Scandinavian Journal of Clinical and Laboratory Investigation 9: 233
• 3 Astrup T, Müllertz S. 1952; The fibrin plate method for estimating fibrinolytic activity. Archives of Biochemistry and Biophysics 40: 346
• 4 Bleyl U, Kuhn W, Graeff H. 1969; Reticuloendotheliale Clearance intravasculer Fibrinmonomere in der Milz. Thrombosis et Diathesis Haemorrhagica 22: 87
• 5 Brakman P, Klug P, Astrup T. 1964; Fibrinolytic activity of thrombin preparations. Thrombosis et Diathesis Haemorrhagica 11: 234
• 6 Deutsch DE, Mertz ET. 1970; Plasminogen: Purification from human plasma by affinity chromatography. Science 170: 1095
• 7 Eichenberger E, Kicköfen M, Schmidhauser-Kopp M, Schünholzer G. 1954; Über die fibrinolytische Wirkung von Thrombin. Schweizerische Medizinische Wochenschrift 84: 65
• 8 Gans H, Lowman JT. 1967; The uptake of fibrin and fibrindegradation products by the isolated perfused rat liver. Blood 29: 526
• 9 Guest MM, Ware AG. 1950; Fibrinolytic activity of purified thrombin. Science 112: 21
• 10 Hermann G, Miescher PA. 1965; Differentiation of leukocytic fibrinolytic enzymes from plasmin by the use of plasmin proteolytic inhibitors. International Archives of Allergy and Applied Immunology 27: 346
• 11 Kang EP, Triantaphyllopoulos DC. 1977; Fibrin digestion by thrombin. Comparison with plasmin-digested fibrinogen Biochimica et Biophysica Acta 490: 430
• 12 Kopitar M, Kregar I, Lebez D. 1971; Leucocytes protease II. Partial purification of proteinases present in cathepsin D preparation. Enzymologia 41: 129
• 13 Kunz F, Constanitni R, Semenitz E, Mikuz G, Schmalzl F, Holzknecht F. 1977; The production of disseminated intravascular coagulation (DIC) by spaced injection of endotoxin in nonpregnant, normolipemic rats. Thrombosis Research 12: 119
• 14 Lahnborg G, Berghem L, Lagergren H, Schildt B. 1976; Influence of thrombin induced disseminated intravascular coagulation on RES function in rabbits. Thrombosis Research 9: 653
• 15 Lassen M. 1952; Heat dénaturation of plasminogen in the fibrin plate method. Acta Physiologica Scandinavica 27: 371
• 16 Lee L, Mccluskey RT. 1962; Immunohistochemical demonstration of the reticuloendothelial clearance of circulating fibrin aggregates. Journal of Experimental Medicine 116: 611
• 17 Miyakawa M, Iuima S. 1960. Antibody formation in germfree animals. Proceeding of the VIII International Congress of Hematology. Tokyo: 341
• 18 Ohlsson K. 1971; Properties of leucocytic protease. Clinica Chemica Acta 32: 399
• 19 Okamoto S, Huikata A, Kinjo K, Kikumoto R, Ohkubo K, Tonomura S, Tamao Y. 1975; A novel series of synthetic thrombin-inhibitors having extremely potent and highly selective action. Kobe Journal of Medical Sciences 21: 43
• 20 Okamoto S, Huikata A, Ikezawa K, Kinjo K, Kikumoto R, Tonomura S, Tamao Y. 1976; A new series of synthetic thrombin-inhibitors (OM-inhibitors) having extremely potent and selective action. Thrombosis Research Supplement II 8: 77
• 21 Okamoto S, Okamoto U. 1962; Amino-methyl-cyclohexane-carboxylic acid: AMCHA. A new potent inhibitor of the fibrinolysis. Keio Journal of Medicine 11: 105
• 22 Okamoto U, Yamamoto J, Nagamatsu Y. 1973; A hematological approach to germfree rats: Concentration of fibrinogen and antiplasmin. Kobe Journal of Medical Sciences 19: 145
• 23 Plow EF, Edgington TS. 1975; An alternative pathway for fibrinolysis I. The cleavage of fibrinogen by leukocyte protease at physiologic pH. Journal of Clinical Investigation 56: 30
• 24 Prokopowicz J. 1968; Distribution of fibrinolytic and proteolytic enzymes in subcellular fractions of human granulocytes. Thrombosis et Diathesis Haemorrhagica 19: 84
• 25 Prose PH, Lee L, Balk SD. 1965; Electron microscopic study of the phagocytic fibrinclearing mechanism. American Journal of Pathology 47: 403
• 26 Riddle JM, Bahnhart MI. 1964; Ultrastructural studies of fibrin dissolution via emigrated polymorphonuclear neutrophils. American Journal of Pathology 45: 805
• 27 Sherman LA, Harwig S, Lee J. 1975; In vitro formation and in vivo clearance of fibrinogen: fibrin complexes. Journal of Laboratory and Clinical Medicine 86: 100